Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 15.306% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) COCCn1c(SCC(=O)NC2CC2)nnc1-c1ccc(Cl)cc1
b.) COc1ccc(Cc2nc3ccc(C(=O)N(C)Cc4nccs4)cc3o2)cc1OC
Answer: b. COc1ccc(Cc2nc3ccc(C(=O)N(C)Cc4nccs4)cc3o2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Cc2nc3ccc(C(=O)N(C)Cc4nccs4)cc3o2)cc1OC
COc1ccc(Cc2nc3ccc(C(=O)N(C)Cc4nccs4)cc3o2)cc1OC
2-[(3,4-dimethoxyphenyl)methyl]-N-methyl-N-(1,3-thiazol-2-ylmethyl)-1,3-benzoxazole-6-carboxamide